Bracco hits Jubilant with patent complaint on rubidium PET
Contrast developer Bracco Diagnostics has filed a complaint against radiopharmaceutical...Read more on AuntMinnie.comRelated Reading:
Bracco lands new FDA approval for MultiHance
Bracco targets gene therapy for ultrasound contrast
Bracco declines comment on Norris gadolinium lawsuit
PBS report targets price hike for V/Q radiotracers
Jubilant Pharma taps new DraxImage president
Jubilant DraxImage, Cyclopharm ink deal
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news